In many healthcare systems, the primary focus is on treating existing illnesses rather than preventing them. Prevention often requires lifestyle changes, regular screenings, and vaccinations, which can be expensive upfront. Moreover, access to affordable preventive care is limited for many, making it challenging to address health issues at their roots. Doctors also often have limited time for in-depth discussions with their patients, which hampers effective communication, patient education, and the development of engaged and trusting long-term relationships.

‍

That’s why we are excited about leading Everlab’s’ AUD 3m pre-seed round. The HealthTech startup’s mission is to eradicate chronic diseases and empower everyone to live a longer and healthier lives by building the first operating system for human health. By automating a suite of tools and protocols that have until now been reserved for the ultra-wealthy, Everlab manages to provide personalized and data-driven health care at scale for a fraction of the cost. The company aims to continuously monitor and improve health, detect diseases early, optimize cognitive and physical performance over your entire life, and make well-being and longevity attainable for the broader population.

‍

Here are some more reasons why we believe in Everlab:

‍

💪🏼 Strong and complementary team with relevant expertise: The team behind Everlab of Marc Hermann, Anshul Jain, Dr. Steven Lu, Sam Kothari possess industry-specific expertise and the necessary skills to successfully develop and scale this solution. We are also very happy to be backing Marc again on his new journey, after supporting his previous venture foodspring back in 2017.

‍

🏥 Hybrid Care Approach: Many digital therapeutic solutions face challenges in establishing a practical value proposition and achieving distribution at scale, making commercialization a daunting task. By seamlessly integrating both physical care and digital therapy, Everlab is well-positioned to pioneer a transformative healthcare experience.

‍

🦘 Australia as launch market: Australia serves as the ideal market for Everlab for several reasons: (1) The society exhibits a strong awareness of health, (2) consumers are accustomed to paying out-of-pocket for healthcare services, (3) the market allocates the highest percentage of healthcare expenditure to primary care globally, and (4) historical medical data is already digitally stored.

‍

🧩 Collection of medical data at scale: Throughout its operations, Everlab will accumulate a diverse range of health data and biomarkers, creating an extensive repository of medical information. This data can serve multiple purposes, including (1) aiding doctors in early disease detection and prevention, (2) providing governments and health ministries with valuable population insights, and (3) potentially advancing healthcare research on a global scale.

‍

⚖️ Market development focusing on increasing spend on preventative healthcare: Following the onset of the COVID-19 pandemic, numerous governments pledged to increase healthcare expenditure, particularly in health promotion and disease prevention. This shift has the potential to expedite public awareness of preventive measures. Furthermore, potential levers for chronic diseases lie well before the point of diagnosis. Yet, today, most of our intervention toolkit is only available after diagnosis, the gating point for attention and resources from most formal healthcare systems. Fortunately, the landscape is beginning to shift. Evidence continues to accumulate that preventive medicine can help improve health outcomes and, in some cases, lower overall healthcare costs. 

‍

Overall, we firmly believe that Everlab has what it takes to eradicate diseases and unlock new possibilities to live a healthier life. We are super excited to be part of this journey 🔮

‍

‍Attention all entrepreneurs and investors: Feel free to reach out to us (jan-hendrik.buerk@b2venture.vc & johanna.junkermann@b2venture.vc) if you are interested to learn more about our view on the market or if you would like to get in touch with the founders.